Merck, Schering-Plough merger fails to stoke sector

News that U.S. drugmakers Merck & Co. and Schering-Plough Corp. plan to merge do little to stoke trading in the sector early Monday, as the benchmark indexes for both the biotech and pharmaceutical sectors followed the broader market south.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.